Cargando…
Neurological, psychiatric, ophthalmological, and endocrine complications in giant male prolactinomas: An observational study in Algerian population
INTRODUCTION: Prolactinomas are less frequent, but more invasive in males. Giant ones (≥4 cm) are extremely rare in literature. Their neurological, psychiatric and endocrine complications are life threatening. Our aim was to report the largest mono center series in order to analyze their frequency,...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366773/ https://www.ncbi.nlm.nih.gov/pubmed/25932390 http://dx.doi.org/10.4103/2230-8210.152771 |
_version_ | 1782362418422218752 |
---|---|
author | Chentli, Farida Azzoug, Said Daffeur, Katia Akkache, Lina Zellagui, Hadjer Haddad, Meriem Kalafate, Nadia |
author_facet | Chentli, Farida Azzoug, Said Daffeur, Katia Akkache, Lina Zellagui, Hadjer Haddad, Meriem Kalafate, Nadia |
author_sort | Chentli, Farida |
collection | PubMed |
description | INTRODUCTION: Prolactinomas are less frequent, but more invasive in males. Giant ones (≥4 cm) are extremely rare in literature. Their neurological, psychiatric and endocrine complications are life threatening. Our aim was to report the largest mono center series in order to analyze their frequency, their characteristics, and their complications. SUBJECTS AND METHODS: All patients had clinical examination, hormonal, ophthalmological, and radiological assessment based on computed tomography scan and cerebral magnetic resonance imaging. Positive diagnosis was based on clinical symptoms, high prolactin ± immunohistochemy study. Mixed adenomas were excluded by hormonal exploration and immunohistochemy. For those who received medical treatment only, a reduction in tumor size was considered a supplementary positive point for the diagnosis. RESULTS: Among 154 male prolactinomas seen between 1987 and 2013, we observed 44 giant tumors (28.5%). Median age = 36 years, and 38.3% were under 30. Median tumor height = 53.95 mm (40–130) and median prolactin = 15,715 ng/ml (n < 20). Solid and cystic aspect ± calcifications was observed in 25%. 42 had cavernous sinuses invasion. Other invasions were: Posterior= 65.9%, anterior= 63.6%, temporal= 15.9% and frontal = 9%. For endocrine complications: Hypogonadism = 98.4%, thyrotroph and corticotroph deficits were seen in respectively 34%, and 32%. Posterior pituitary insufficiency was observed in one case. For ophthalmological complications: Optic atrophy = 46%, Ptosis = 6.8%, diplopia/strabismus = 4.5%. Neurological complications were: Memory loss and/or unconsciousness = 18.2%, epilepsy = 15.9%, frontal syndrome = 9% and obstructive hydrocephalus = 6.8%. CONCLUSION: Giant prolactinomas account for 28% in our population. Severe neurological complications are frequent. But, obstructive hydrocephalus is rare, which argues for a slow progression. |
format | Online Article Text |
id | pubmed-4366773 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-43667732015-05-01 Neurological, psychiatric, ophthalmological, and endocrine complications in giant male prolactinomas: An observational study in Algerian population Chentli, Farida Azzoug, Said Daffeur, Katia Akkache, Lina Zellagui, Hadjer Haddad, Meriem Kalafate, Nadia Indian J Endocrinol Metab Original Article INTRODUCTION: Prolactinomas are less frequent, but more invasive in males. Giant ones (≥4 cm) are extremely rare in literature. Their neurological, psychiatric and endocrine complications are life threatening. Our aim was to report the largest mono center series in order to analyze their frequency, their characteristics, and their complications. SUBJECTS AND METHODS: All patients had clinical examination, hormonal, ophthalmological, and radiological assessment based on computed tomography scan and cerebral magnetic resonance imaging. Positive diagnosis was based on clinical symptoms, high prolactin ± immunohistochemy study. Mixed adenomas were excluded by hormonal exploration and immunohistochemy. For those who received medical treatment only, a reduction in tumor size was considered a supplementary positive point for the diagnosis. RESULTS: Among 154 male prolactinomas seen between 1987 and 2013, we observed 44 giant tumors (28.5%). Median age = 36 years, and 38.3% were under 30. Median tumor height = 53.95 mm (40–130) and median prolactin = 15,715 ng/ml (n < 20). Solid and cystic aspect ± calcifications was observed in 25%. 42 had cavernous sinuses invasion. Other invasions were: Posterior= 65.9%, anterior= 63.6%, temporal= 15.9% and frontal = 9%. For endocrine complications: Hypogonadism = 98.4%, thyrotroph and corticotroph deficits were seen in respectively 34%, and 32%. Posterior pituitary insufficiency was observed in one case. For ophthalmological complications: Optic atrophy = 46%, Ptosis = 6.8%, diplopia/strabismus = 4.5%. Neurological complications were: Memory loss and/or unconsciousness = 18.2%, epilepsy = 15.9%, frontal syndrome = 9% and obstructive hydrocephalus = 6.8%. CONCLUSION: Giant prolactinomas account for 28% in our population. Severe neurological complications are frequent. But, obstructive hydrocephalus is rare, which argues for a slow progression. Medknow Publications & Media Pvt Ltd 2015 /pmc/articles/PMC4366773/ /pubmed/25932390 http://dx.doi.org/10.4103/2230-8210.152771 Text en Copyright: © Indian Journal of Endocrinology and Metabolism http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Chentli, Farida Azzoug, Said Daffeur, Katia Akkache, Lina Zellagui, Hadjer Haddad, Meriem Kalafate, Nadia Neurological, psychiatric, ophthalmological, and endocrine complications in giant male prolactinomas: An observational study in Algerian population |
title | Neurological, psychiatric, ophthalmological, and endocrine complications in giant male prolactinomas: An observational study in Algerian population |
title_full | Neurological, psychiatric, ophthalmological, and endocrine complications in giant male prolactinomas: An observational study in Algerian population |
title_fullStr | Neurological, psychiatric, ophthalmological, and endocrine complications in giant male prolactinomas: An observational study in Algerian population |
title_full_unstemmed | Neurological, psychiatric, ophthalmological, and endocrine complications in giant male prolactinomas: An observational study in Algerian population |
title_short | Neurological, psychiatric, ophthalmological, and endocrine complications in giant male prolactinomas: An observational study in Algerian population |
title_sort | neurological, psychiatric, ophthalmological, and endocrine complications in giant male prolactinomas: an observational study in algerian population |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366773/ https://www.ncbi.nlm.nih.gov/pubmed/25932390 http://dx.doi.org/10.4103/2230-8210.152771 |
work_keys_str_mv | AT chentlifarida neurologicalpsychiatricophthalmologicalandendocrinecomplicationsingiantmaleprolactinomasanobservationalstudyinalgerianpopulation AT azzougsaid neurologicalpsychiatricophthalmologicalandendocrinecomplicationsingiantmaleprolactinomasanobservationalstudyinalgerianpopulation AT daffeurkatia neurologicalpsychiatricophthalmologicalandendocrinecomplicationsingiantmaleprolactinomasanobservationalstudyinalgerianpopulation AT akkachelina neurologicalpsychiatricophthalmologicalandendocrinecomplicationsingiantmaleprolactinomasanobservationalstudyinalgerianpopulation AT zellaguihadjer neurologicalpsychiatricophthalmologicalandendocrinecomplicationsingiantmaleprolactinomasanobservationalstudyinalgerianpopulation AT haddadmeriem neurologicalpsychiatricophthalmologicalandendocrinecomplicationsingiantmaleprolactinomasanobservationalstudyinalgerianpopulation AT kalafatenadia neurologicalpsychiatricophthalmologicalandendocrinecomplicationsingiantmaleprolactinomasanobservationalstudyinalgerianpopulation |